UnknownPhase 4NCT05221411

Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy

Studying Autoimmune hepatitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Leiden University Medical Center
Principal Investigator
Bart van Hoek
Leiden University Medical Center
Intervention
Mycophenolate Mofetil(drug)
Enrollment
86 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2024

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05221411 on ClinicalTrials.gov

Other trials for Autoimmune hepatitis

Additional recruiting or active studies for the same condition.

See all trials for Autoimmune hepatitis →

← Back to all trials